External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

CTAD 2024

-
07:45 AM
Duration 15mins Madrid Marriott Auditorium Hotel & Conference Center
LATEST INTERIM RESULTS FROM THE BRAINSHUTTLE™ AD STUDY, A PHASE IB/IIA STUDY OF TRONTINEMAB IN PEOPLE WITH ALZHEIMER’S DISEASE
Luka Kulic

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
06:15 AM
Duration 24hrs Madrid, Spain
Evaluation of the effects of repeated lumbar punctures on Alzheimer’s Disease CSF and blood biomarkers
Anne Biever

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 24hrs Madrid, Spain
Concordance between the updated Elecsys CSF immunoassays and amyloid PET for the diagnosis of Alzheimer’s disease: findings from the Apollo study
Henrik Schinke

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 24hrs Madrid, Spain
Revamping Alzheimer's Disease Diagnostics: Evaluating Future IVD Plasma p-Tau 181 and ApoE4 Immunoassays for Amyloid Detection in a Multi-Center Study Reflective of Routine Clinical Practice
Clara Quijano-Rubio

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 24hrs Madrid, Spain
Head-to-head comparison of the fully automated Elecsys pTau217 plasma assay and the Lumipulse pTau217 plasma assay
Robert Pernezcky

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Coming soon